Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)

Iqvia Holdings' (IQV) quarterly Cash from Financing Activities came in at -$214.0 million in Q2 2026, down 247.59% year-over-year from $145.0 million in Q2 2025, and up 50.58% quarter-over-quarter from -$433.0 million in Q1 2026.

Analysis

Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends

Iqvia Holdings has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$214.0 million for Q2 2026.

  • In Q2 2026, Cash from Financing Activities fell 247.59% year-over-year to -$214.0 million; the TTM figure through Jun 2026 stood at -$684.0 million (down 9.44% YoY), while the FY2025 annual figure was -$150.0 million, up 82.92% from the prior year.
  • Cash from Financing Activities came in at -$214.0 million for Q2 2026 at Iqvia Holdings, up from -$433.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $535.0 million in Q4 2025 to a low of -$572.0 million in Q3 2025.
  • Average Cash from Financing Activities over 5 years is -$132.6 million, with a median of -$168.5 million recorded in 2022.
  • Year-over-year, Cash from Financing Activities surged 427.59% in 2023 and plunged 373.68% in 2024.
  • Over 5 years, Cash from Financing Activities stood at -$193.0 million in 2022, then sank by 117.62% to -$420.0 million in 2023, then grew by 10.71% to -$375.0 million in 2024, then jumped by 242.67% to $535.0 million in 2025, then tumbled by 140.0% to -$214.0 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were -$214.0 million in Q2 2026, -$433.0 million in Q1 2026, and $535.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -214.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -288.34 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -8.12 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -164.66 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 16.49 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 248,151.59
10 VivoSim Labs 1.37 Mn 1.37 Mn - -118,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -214.00 Mn
Mar 31, 2026 -433.00 Mn
Dec 31, 2025 535.00 Mn
Sep 30, 2025 -572.00 Mn
Jun 30, 2025 145.00 Mn
Mar 31, 2025 -258.00 Mn
Dec 31, 2024 -375.00 Mn
Sep 30, 2024 -137.00 Mn
Jun 30, 2024 -260.00 Mn
Mar 31, 2024 -106.00 Mn
Dec 31, 2023 -420.00 Mn
Sep 30, 2023 -144.00 Mn
Jun 30, 2023 95.00 Mn
Mar 31, 2023 87.00 Mn
Dec 31, 2022 -193.00 Mn
Sep 30, 2022 -251.00 Mn
Jun 30, 2022 -29.00 Mn
Mar 31, 2022 144.00 Mn
Dec 31, 2021 -138.00 Mn
Sep 30, 2021 -66.00 Mn